Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
PTLF:USOTC US

Petlife Pharmaceuticals Inc

COMPANY INFO
0.00USD
+-0.00-47.50%
Market Closed
As of 08/16/2019 EDT
Open
0.00
Prev Close
0.00
Volume
32,600
Market Cap
413.179K
Day Range
0.000.00
52 Week Range
0.000.05
1D1M1Y5Y
View Full Chart
Market Closed
As of 08/16/2019 EDT
1D1M1Y5Y
View Full Chart
markets
Walmart Jumps Most in a Year on Strong 2Q Sales
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio--
Bloomberg (BEst) P/E Ratio--
Bloomberg (BEst) PEG Ratio--
Shares Outstanding196.75M
Price to Book Ratio--
Price to Sales Ratio--
1 Year Return-73.75%
30 Day Avg Volume1,551
EPS-0.04
Bloomberg (BEst) EPS Curr Yr--
Dividend--
Last Dividend Reported--

Compare
1-Day Performance

-50%0
-50%0
Equity
PTLF:US
-47.50%
Sponsored By

About Petlife Pharmaceuticals Inc

Petlife Pharmaceuticals, Inc., is a U.S. veterinary pharmaceutical company. The Company is working on medications and nutraceuticals for veterinary oncology.
Address
7432 East Highway 50 Groveland, FL 34736 United States
Phone
1-352-557-4830
Website
uspetlife.com

Income Statement

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q2 2018 (Millions USD)
  • Revenue
    --
  • Net Income
    --
  • Profit Margin
    --%

Balance Sheet

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q2 2018 (Millions USD)
  • Total Assets
    --
  • Total Liabilities
    --
  • Debt to Assets
    --%

Cash Flow

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q2 2018 (Millions USD)
  • Operating
    --
  • Investing
    --
  • Financing
    --